The US Food and Drug Administration warned that the benefits of fluoroquinolone antibiotics do not outweigh the risks — which include aortic aneurysm — for certain patients, according to the latest research. The research is based on reports of patient problems and on studies published between 2015 and 2018.

Efforts to conquer antimicrobial resistance are being jeopardized in India due to the sale of huge volumes of antibiotics that combine two antimicrobial drugs in one pill, our latest analysis revealed.